Sectors
SLXN
Silexion Therapeutics Corp
0.37
2 x 0.25
2 x 0.46
bid
ask
+
0.01
1.90%
2 @ 07:30 PM
0.37 +0.00 (0.05%)
| Ytd | -98.07% | |
| 1y | -99.49% |
0.36
day range
0.38
0.35
52 week range
77.70
| Open | 0.37 | Prev Close | 0.36 | Low | 0.36 | High | 0.38 | Mkt Cap | 2.06M |
| Vol | 155.69K | Avg Vol | 282.21K | EPS | -19.89 | P/E | N/A | Forward P/E | -3.95 |
| Beta | -0.11 | Short Ratio | 0.23 | Inst. Own | 8.15% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 1.85 | 200-d Avg | 12.13 | 1yr Est | 9.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-14 | 2024-09 | 0 | -18.27 | N/A | N/A |
| 2011-05-16 | 2011-03 | 0 | N/A | N/A | N/A |
| 2011-03-08 | 2010-12 | 0 | N/A | N/A | N/A |
| 2010-12-06 | 2010-09 | 0 | N/A | N/A | N/A |
| 2010-09-03 | 2010-06 | 0 | N/A | N/A | N/A |
| 2010-06-04 | 2010-03 | 0 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-11-01 | Maxim Group | Upgrade | Buy |
Profile
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Wildcat Capital Management, LLC | 113.43K | 286.97K | 0.79% |
| 2024-09-29 | HRT Financial LP | 10.00K | 25.29K | 0.07% |
| 2024-09-29 | Virtu Financial LLC | 2.96K | 7.49K | 0.02% |
| 2024-09-29 | Two Sigma Securities, LLC | 1.68K | 4.25K | 0.01% |
| 2024-09-29 | UBS Group AG | 1.67K | 4.23K | 0.01% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 587.00 | 1.49K | 0.00% |